Effects of subinhibitory concentrations of chlorhexidine and mupirocin on biofilm formation in clinical meticillin-resistant Staphylococcus aureus. Issue 2 (October 2020)
- Record Type:
- Journal Article
- Title:
- Effects of subinhibitory concentrations of chlorhexidine and mupirocin on biofilm formation in clinical meticillin-resistant Staphylococcus aureus. Issue 2 (October 2020)
- Main Title:
- Effects of subinhibitory concentrations of chlorhexidine and mupirocin on biofilm formation in clinical meticillin-resistant Staphylococcus aureus
- Authors:
- Park, K.-H.
Jung, M.
Kim, D.Y.
Lee, Y.-M.
Lee, M.S.
Ryu, B.-H.
Hong, S.I.
Hong, K.-W.
Bae, I.-G.
Cho, O.-H. - Abstract:
- Summary: Background: The effects of subinhibitory concentrations (sub-MICs) of antibacterial agents on the biofilm-forming ability of Staphylococcus aureus require further study. Aim: To investigate the effects of sub-MICs of chlorhexidine and mupirocin on biofilm formation in clinical meticillin-resistant Staphylococcus aureus (MRSA) isolates. Methods: MRSA isolates were collected from patients with bloodstream infections at a tertiary care hospital. The basal level of biofilm formation and biofilm induction by sub-MICs of chlorhexidine and mupirocin were evaluated by measuring biofilm mass stained with Crystal Violet. Findings: Of the 112 MRSA isolates tested, 63 (56.3%) and 44 (39.3%) belonged to sequence type (ST)5 and ST72 lineages, respectively, which are the predominant healthcare- and community-associated clones in South Korea. ST5 isolates were more likely to have chlorhexidine MIC ≥4 (73.0% vs 29.5%), resistance to mupirocin (23.8% vs 0%), agr dysfunction (73.0% vs 9.1%), and qac A/B gene (58.7% vs 2.3%) compared to ST72 isolates. The basal level of biofilm formation ability was frequently stronger in ST72 isolates compared to ST5 isolates (77.3% vs 12.7%). Sub-MICs of chlorhexidine and mupirocin promoted biofilm formation in 56.3% and 53.6%, respectively, of all isolates. Biofilm induction was more prevalent in ST5 isolates (85.7% for chlorhexidine, 69.8% for mupirocin) than in ST72 isolates (15.9% for chlorhexidine, 27.3% for mupirocin). Conclusion: Sub-MICs ofSummary: Background: The effects of subinhibitory concentrations (sub-MICs) of antibacterial agents on the biofilm-forming ability of Staphylococcus aureus require further study. Aim: To investigate the effects of sub-MICs of chlorhexidine and mupirocin on biofilm formation in clinical meticillin-resistant Staphylococcus aureus (MRSA) isolates. Methods: MRSA isolates were collected from patients with bloodstream infections at a tertiary care hospital. The basal level of biofilm formation and biofilm induction by sub-MICs of chlorhexidine and mupirocin were evaluated by measuring biofilm mass stained with Crystal Violet. Findings: Of the 112 MRSA isolates tested, 63 (56.3%) and 44 (39.3%) belonged to sequence type (ST)5 and ST72 lineages, respectively, which are the predominant healthcare- and community-associated clones in South Korea. ST5 isolates were more likely to have chlorhexidine MIC ≥4 (73.0% vs 29.5%), resistance to mupirocin (23.8% vs 0%), agr dysfunction (73.0% vs 9.1%), and qac A/B gene (58.7% vs 2.3%) compared to ST72 isolates. The basal level of biofilm formation ability was frequently stronger in ST72 isolates compared to ST5 isolates (77.3% vs 12.7%). Sub-MICs of chlorhexidine and mupirocin promoted biofilm formation in 56.3% and 53.6%, respectively, of all isolates. Biofilm induction was more prevalent in ST5 isolates (85.7% for chlorhexidine, 69.8% for mupirocin) than in ST72 isolates (15.9% for chlorhexidine, 27.3% for mupirocin). Conclusion: Sub-MICs of chlorhexidine and mupirocin promoted biofilm formation in half of the clinical MRSA isolates. Our results suggest that ST5 MRSA biofilm can be induced together with some other bacterial virulent factors following exposure to chlorhexidine, which might confer a survival advantage to this clone in the healthcare environment. … (more)
- Is Part Of:
- Journal of hospital infection. Volume 106:Issue 2(2020)
- Journal:
- Journal of hospital infection
- Issue:
- Volume 106:Issue 2(2020)
- Issue Display:
- Volume 106, Issue 2 (2020)
- Year:
- 2020
- Volume:
- 106
- Issue:
- 2
- Issue Sort Value:
- 2020-0106-0002-0000
- Page Start:
- 295
- Page End:
- 302
- Publication Date:
- 2020-10
- Subjects:
- Staphylococcus aureus -- Biofilm -- Chlorhexidine -- Mupirocin
Cross infection -- Periodicals
Cross infection -- Prevention -- Periodicals
Nosocomial infections -- Periodicals
Nosocomial infections -- Prevention -- Periodicals
Cross Infection -- Periodicals
Cross Infection -- prevention & control -- Periodicals
Infection Control -- Periodicals
Electronic journals
614.44 - Journal URLs:
- http://www.harcourt-international.com/journals ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01956701 ↗
http://www.sciencedirect.com/science/journal/01956701 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.jhin.2020.07.010 ↗
- Languages:
- English
- ISSNs:
- 0195-6701
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5003.285000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 14367.xml